ZePeptideBPC-157
Ordered BPC-157 from ZePeptide? Mail in a sample (US only) and let us test it for free.
Test my supplyZePeptide's BPC-157 profile is held back by fill volatility: identity checks passed, but one vial was +51% with 98.8% purity and another was +62%. Subsequent in-range results help, yet sparse batch IDs keep consistency uncertain.
Corporate records, backdated web content, and a shared analytics tag trace ZePeptide from a suspended storefront into a wider domain network. The report follows the payment rails, COA-mismatch claims, and a hyphenated site using another Chinese company’s identity.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including ZePeptide rows.
Cancel anytime
About ZePeptide test results from Finnrick
ZePeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 96 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible ZePeptide peptides in this dataset are BPC-157 (10 tests), GHK-Cu (10 tests) and Ipamorelin (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 96 recent tests. It also includes 2 corrections related to this vendor.
Ordered BPC-157 from ZePeptide? Mail in a sample (US only) and let us test it for free.
Test my supply